EE04235B1 - Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks - Google Patents
Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviksInfo
- Publication number
- EE04235B1 EE04235B1 EEP200000290A EEP200000290A EE04235B1 EE 04235 B1 EE04235 B1 EE 04235B1 EE P200000290 A EEP200000290 A EE P200000290A EE P200000290 A EEP200000290 A EE P200000290A EE 04235 B1 EE04235 B1 EE 04235B1
- Authority
- EE
- Estonia
- Prior art keywords
- tetrahydropyridines
- alzheimer
- namely
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714322A FR2771007B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
FR9714324A FR2771006B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
PCT/FR1998/002384 WO1999025363A1 (fr) | 1997-11-14 | 1998-11-09 | Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200000290A EE200000290A (et) | 2001-06-15 |
EE04235B1 true EE04235B1 (et) | 2004-02-16 |
Family
ID=26233932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200000290A EE04235B1 (et) | 1997-11-14 | 1998-11-09 | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1030671A1 (et) |
JP (1) | JP2001523642A (et) |
KR (1) | KR100599350B1 (et) |
CN (1) | CN1243540C (et) |
AU (1) | AU743228B2 (et) |
BG (1) | BG64819B1 (et) |
BR (1) | BR9814035A (et) |
CA (1) | CA2309966A1 (et) |
CO (1) | CO4980891A1 (et) |
DZ (1) | DZ2649A1 (et) |
EA (1) | EA003255B1 (et) |
EE (1) | EE04235B1 (et) |
HU (1) | HUP0100098A3 (et) |
ID (1) | ID24933A (et) |
IL (2) | IL136122A0 (et) |
IS (1) | IS5482A (et) |
MY (1) | MY120461A (et) |
NO (1) | NO20002450L (et) |
NZ (1) | NZ504420A (et) |
OA (1) | OA11464A (et) |
PL (1) | PL194597B1 (et) |
SA (1) | SA98190747B1 (et) |
SK (1) | SK286040B6 (et) |
TR (1) | TR200001262T2 (et) |
TW (1) | TW585766B (et) |
UY (1) | UY25247A1 (et) |
WO (1) | WO1999025363A1 (et) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL165589A (en) * | 2002-06-14 | 2012-04-30 | Toyama Chemical Co Ltd | Pharmaceutical preparation to improve brain function and use |
ATE435302T1 (de) * | 2002-08-07 | 2009-07-15 | Novartis Pharma Gmbh | Verfahren zur vorhersage des behandlungserfolgs mit rivastigmine basierend auf einer bestimmung des apoe genotyps eines demenzkranken |
CN1520818A (zh) * | 2003-02-09 | 2004-08-18 | 山东绿叶天然药物研究开发有限公司 | 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物 |
MX2007007836A (es) | 2004-12-27 | 2007-08-20 | Eisai R&D Man Co Ltd | Metodo para estabilizar un farmaco anti-demencia. |
KR102331422B1 (ko) | 2014-01-31 | 2021-11-25 | 카그니션 테라퓨틱스, 인코퍼레이티드 | 아이소인돌린 조성물 및 신경퇴행성 질환을 치료하는 방법 |
JP7218306B2 (ja) | 2017-05-15 | 2023-02-06 | コグニション セラピューティクス インク. | 神経変性疾患を治療するための組成物 |
WO2019182319A1 (ko) * | 2018-03-20 | 2019-09-26 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
KR102224917B1 (ko) | 2018-03-20 | 2021-03-09 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
CN109265391B (zh) * | 2018-11-13 | 2021-11-19 | 枣庄学院 | 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
JPH11511732A (ja) * | 1995-03-06 | 1999-10-12 | インターニューロン ファーマシューティカルズ,インコーポレーテッド | シチコリンを用いる梗塞容積の低減 |
FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
-
1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/es unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/zh not_active IP Right Cessation
- 1998-11-09 SK SK711-2000A patent/SK286040B6/sk unknown
- 1998-11-09 PL PL98340500A patent/PL194597B1/pl not_active IP Right Cessation
- 1998-11-09 ID IDW20000860A patent/ID24933A/id unknown
- 1998-11-09 EE EEP200000290A patent/EE04235B1/et not_active IP Right Cessation
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/ja not_active Withdrawn
- 1998-11-09 EP EP98954538A patent/EP1030671A1/fr not_active Withdrawn
- 1998-11-09 CN CNB988130947A patent/CN1243540C/zh not_active Expired - Fee Related
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/fr not_active Application Discontinuation
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/xx unknown
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/hu unknown
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 IL IL13612298A patent/IL136122A0/xx not_active IP Right Cessation
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/ko not_active IP Right Cessation
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/pt not_active Application Discontinuation
- 1998-11-09 EA EA200000412A patent/EA003255B1/ru not_active IP Right Cessation
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/xx active
- 1998-11-12 UY UY25247A patent/UY25247A1/es not_active IP Right Cessation
- 1998-11-14 SA SA98190747A patent/SA98190747B1/ar unknown
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
-
2000
- 2000-05-09 IS IS5482A patent/IS5482A/is unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/no unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/bg unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE253361T1 (de) | Mittel zur gesteuerten freisetzung von paroxetin | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE69806801T2 (de) | Galenische präparation zur prävention und behandlung von hepatokarzinomen | |
DE60022867D1 (de) | 1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen | |
NO990433D0 (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
NO20051757D0 (no) | Fremgangsmõte ved fremstilling av 2-azadihydroksybicyklo [2.2.2]-heptanforbindelser samt L-tartarsyresalter av forbindelsene | |
HUP9900927A3 (en) | Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases | |
AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
EE04235B1 (et) | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks | |
AU3364499A (en) | Method for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders | |
DE69838785D1 (de) | Pharmazeutische mittel zur behandlung von zerebralen amyloidosis | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
ATE234617T1 (de) | Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression | |
PT888114E (pt) | Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares | |
ATE346840T1 (de) | Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung | |
GR3033316T3 (en) | Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders | |
NO981499L (no) | FremgangsmÕte for fremstilling av titandioksyd | |
NO20003145D0 (no) | FremgangsmÕte for fremstilling av paroxetine-hydroklorid | |
NO20014026D0 (no) | Krampestillende derivater til behandling av betydelig skjelving | |
KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
FR2718027B1 (fr) | Produit destiné au traitement et à la prévention des alopécies. | |
ZA989955B (en) | Combination of active ingredients for the treatment of senile dementia of the alzheimer type | |
ZA974390B (en) | Carboxamide derivatives of pyrrolidine piperidine and hexahydroazepine for the treatment of thrombosis disorders. | |
FI970269A0 (fi) | 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HD1A | Correction of address | ||
HC1A | Change of owner name | ||
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20081109 |